| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2016 | Pappajohn John | Director, 10% Owner | Buy | 16 | $7.50 | $120.00 | - | |
| Oct 10, 2016 | Pappajohn John | Director, 10% Owner | Buy | 1,839 | $6.45 | $11,866.52 | +0.5% |